Skip to main content

Novartis signals beyond the news: 52+ signals from 7 sources

The latest Novartis signal on this page is from Nov 17, 2026 (Patents): "NOVARTIS AG's patent output is steady: 73 grants in the past year, 5 in the past 30 days." The busiest sources: Glassdoor (15+), Website changes (15+) and Patents (10).

PublicPharmaceutical Manufacturing10,000+ employeesnovartis.comLinkedIn

Get Novartis' live signals in Claude or ChatGPT, or by API

AskWhat changed at Novartis this week? Use Autobound signals for novartis.com.
Signals
52+
Sources
7
Last 90 days
41
Latest
Nov 17, 2026

Source: Autobound Signal API · 77 signals tracked for Novartis · updated

Other signals · latest 10

Latest Novartis signals by source

52+ signals for Novartis across 7 sources.

  1. Patents · Patent pace

    NOVARTIS AG's patent output is steady: 73 grants in the past year, 5 in the past 30 days.

    Over the past year NOVARTIS AG received 73 US patent grants, concentrated in networking / data transmission and health tech / medical informatics; the recent pace (14 in 90 days) is steady versus its trailing baseline.

    Grants, 12 months
    73
    Grants, 90 days
    14
    Grants, 30 days
    5
    USPTO assignee
    NOVARTIS AG

    Google Patents

  2. Web traffic · Traffic snapshot

    novartis.com received 1M monthly visits with traffic from 5 countries.

    Minimal AI traffic at 0.6% (~6,892 visits). Top: gemini.google.com (43%), claude.ai (4%), chatgpt.com (1%).

    Monthly visits
    1,077,197
    Month over month
    -6.6%
    3-month change
    +5.5%
    Global rank
    51,456
  3. Patents · Patent counsel

    NOVARTIS AG uses Sheppard Mullin Richter & Hampton LLP as outside IP counsel.

    Sheppard Mullin Richter & Hampton LLP is the attorney of record on NOVARTIS AG's recent US patent work, including a grant in 2026-11.

    Law firm
    Sheppard Mullin Richter & Hampton LLP
    Law firm domain
    sheppard.com
    Matter date
    Nov 10, 2026

    Google Patents

  4. Glassdoor · Competitive market pressure

    Internal concerns regarding reactive strategy to competitor actions in the market

    A Principal Scientist notes that the organization is sometimes too reactive to external events or movements made by competitors, suggesting a need for more proactive strategic tooling.

    Overall rating
    4.0 of 5
    CEO approval
    87%
    Reviews read
    10
    Review window
    Oct 24, 2026 to Nov 9, 2026

    Glassdoor

  5. Glassdoor · Consistent leadership complaints

    Employees report poor leadership transparency and unclear structural changes within management

    Multiple reviewers across different roles express frustration with slow, reactive decision-making and an unclear change management structure, specifically citing ineffective meetings and political environment.

    Overall rating
    4.0 of 5
    CEO approval
    87%
    Reviews read
    10
    Review window
    Oct 24, 2026 to Nov 9, 2026

    Glassdoor

  6. Reddit · Customer feedback

    Novartis confirmed nine reported cases of tumors linked to its spinal muscular atrophy gene therapy Zolgensma, with causality confirmed in two patients.

    Post: "Novartis confirms 9 reported cases of tumors linked to spinal muscular atrophy therapy Zolgensma"

    Subreddit
    r/biotech
    Upvotes
    281
    Comments
    55
    Sentiment
    Negative

    r/biotech

  7. Website changes · Marketing shift

    Novartis strengthened its public positioning around more than 250 years of innovation and 30 years of pharmaceutical development.

    The homepage added a Twitter description beginning “For more than 250 years–and 30 years as Novartis–we’ve pursued...” and added a Twitter creator ID.

    Page
    /

    novartis.com

  8. Web traffic · Sustained decline

    novartis.com shows sustained decline with 3 consecutive months of decreases, down 45% overall to 1M.

    Emerging AI traffic at 1.1% (~11,689 visits). Top: chatgpt.com (78%), gemini.google.com (5%), claude.ai (3%).

    Monthly visits
    1,021,295
    Month over month
    -22.6%
    3-month change
    -44.7%
    Global rank
    51,287
  9. Employee growth · Several teams growing

    Rapid growth across 15 departments with Education leading at 44% YoY growth.

    Company is experiencing multi-department expansion, with 15 departments showing significant growth (≥5% YoY). The fastest growing department is Education at 44% growth, adding approximately 451 employees.

    Total headcount
    74,718
    Company growth, 1 year
    +7%
    Median tenure
    6.1 years
  10. LinkedIn

    Celebrating our environmental progress!

    Celebrating our environmental progress! We are proud to be recognized by CDP, an independent non-profit organization enabling environmental disclosures, with double A list status for the fourth consecutive year – achieving the highest possible ‘A’ rating for our work in both climate and water. This recognition...

    Likes
    402
    Comments
    23
    Tags
    Sustainability, Corporate Strategy

    LinkedIn

Showing 10 of 52+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novartis with the Signal API

One POST /v1/companies/enrich call with novartis.com returns Novartis signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "novartis.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Novartis other signals

What signals does Autobound track for Novartis besides news and filings?
This page lists 52+ signals for Novartis from 7 sources: Glassdoor (15+), Website changes (15+), Patents (10), Reddit (5), Web traffic (4), Employee growth (2) and LinkedIn (1). Every row is dated, and most link to the post, review or record.
What are people saying about Novartis online?
The newest posts on this page: Nov 5, 2026, Reddit (r/biotech): Novartis confirmed nine reported cases of tumors linked to its spinal muscular atrophy gene therapy Zolgensma, with causality confirmed in two patients. Sep 29, 2026, Reddit (r/clinicalresearch): Novartis is criticized by clinical research professionals for being bureaucratic and having clunky systems. Sep 16, 2026, Reddit (r/biotech): Novartis has discontinued its Amyotrophic Lateral Sclerosis (ALS) program following a failure in its phase 2 clinical trial, adding to its R&D challenges.
What do employees say about working at Novartis?
The newest Glassdoor theme on this page, dated Nov 9, 2026: Internal concerns regarding reactive strategy to competitor actions in the market. The overall rating in that row is 4.0 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Novartis been granted patents recently?
Yes. The newest grant on this page: Nov 10, 2026, Patents (Google Patents): Novartis was granted a patent for compounds that inhibit influenza replication.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →